COVID-19患者的重症监护:印度重症医学会立场声明更新
该文是印度重症医学会(ISCCM)对其2020年5月发布的COVID-19重症患者管理立场声明的更新补充。随着对疾病病理生理和严重程度认识的深入,多项随机对照试验和Meta分析在数月内发表,一些疫情初期显示有前景的干预和疗法在后续设计良好的试验中未能显示获益。氧输送和通气方法的认识也在过去数月有所演变。ISCCM审查了自5月立场声明发布以来出现的新证据,形成了更新证据的附录。
要点
- ISCCM对2020年5月立场声明进行证据更新,形成附录。
- 多项RCT和Meta分析在数月内发表,更新了证据基础。
- 部分疫情初期显示有前景的干预在后续设计良好的试验中未能显示获益。
- 氧输送和通气方法的认识在过去数月有所演变。
- 更新基于自5月立场声明发布以来出现的新证据。
研究设计与关键结果
- 印度重症医学会(ISCCM)审查了自其2020年5月立场声明发布以来出现的新证据,形成更新证据的附录。
- 多项随机对照试验和Meta分析在数月内发表。
- 部分疫情初期显示有前景的干预和疗法在后续设计良好的试验中未能显示获益。
- 对氧输送和通气方法的认识在过去数月有所演变。
证据类型、等级与局限
- 证据类型:学会立场声明更新(基于RCT和Meta分析的证据审查)。
- 局限:原文未报告局限性
对床旁实践的改变
- 原文未据此给出推荐
指南或共识出处
- Indian Society of Critical Care Medicine (ISCCM) position statement update, Indian J Crit Care Med 2020;24(Suppl 5):S225-S230.
提炼说明
- 本条依据论文摘要整理;摘要未涉及「适用人群与场景」「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
The management of coronavirus disease-2019 (COVID-19) is witnessing a change as we learn more about the pathophysiology and the severity of the disease. Several randomized controlled trials (RCTs) and meta-analysis have been published over the last few months. Several interventions and therapies which showed promise in the initial days of the pandemic have subsequently failed to show benefit in well-designed trials. Understanding of the methods of oxygen delivery and ventilation have also evolved over the past few months. The Indian Society of Critical Care Medicine (ISCCM) has reviewed the evidence that has emerged since the publication of its position statement in May and has put together an addendum of updated evidence. How to cite this article: Mehta Y, Chaudhry D, Abraham OC, Chacko J, Divatia J, Jagiasi B, et al. Critical Care for COVID-19 Affected Patients: Position Statement of the Indian Society of Critical Care Medicine. Indian J Crit Care Med 2020;24(Suppl 5):S225-S230.
参考来源
- Mehta Y, Chaudhry D, Abraham OC, et al. Critical Care for COVID-19 Affected Patients: Updated Position Statement of the Indian Society of Critical Care Medicine. Indian J Crit Care Med. 2020. PMID: 33354047. doi:10.5005/jp-journals-10071-23621
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。